| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66d345ca3dc5418793276e7bae52494c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a45ea6a25e80a6beec104a1c6535463b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9897c7a4b515ab1ec804893453a6f43f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81e61f2fca9d2ff3169d437e3756f8e4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 |
| filingDate |
2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69746927398755c8342f93fc3b973c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8af62d79bccf1c1037614d1c95753f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b50405c2bd18d8b9c1ab4073ef3feb |
| publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012177151-A1 |
| titleOfInvention |
Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation |
| abstract |
This invention relates to a veterinary antiparasitic solubilised composition including a macrocyclic lactone or a pharmaceutically equivalent salt thereof, and levamisole or a pharmaceutically equivalent salt thereof, characterised in that the pH of the composition is in the range of 2.0 to 5.0 and wherein the composition includes at least one surfactant and at least one antioxidant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015064680-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015064680-A1 |
| priorityDate |
2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |